Moreover, hepcidin expression correlates with several markers of epithelial-to-mesenchymal transition, a phenomenon involved in the cancer metastatic process, and the inhibition of hepcidin in CRC cells reduces such markers [55]. The gene discussed is HAMP; the disease is cancer.